BXSL:NYSEBlackstone Secured Lending Fund Analysis
Data as of 2026-05-22 - not real-time
$23.33
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Blackstone Secured Lending Fund (BXSL) trades at $23.33, well below its 20‑day ($24.06) and 50‑day ($23.98) moving averages and the 200‑day SMA of $26.12, suggesting a pricing discount. PE of 12.2 versus the industry average of 16.8 and a price‑to‑book of 0.89 reinforce an undervalued valuation, while the upside potential of roughly 7.5% aligns with analyst target prices around $25.1‑$25.25. The fund delivers an eye‑catching 13% dividend yield, but a payout ratio of 161% and a recent jump in non‑accrual loans to 3.1% raise questions about dividend sustainability. Q1 2026 net investment income of $0.77 per share covered the quarterly dividend, yet operating cash flow remains negative at -$634 M, highlighting cash‑generation pressure. Leverage is substantial, with total debt of $8.03 B and a debt‑to‑equity ratio of 132, which amplifies credit and liquidity risk. Technical indicators are mixed: RSI at 40.7 signals neutral momentum, while a bearish MACD and decreasing volume suggest short‑term weakness. The fund’s beta of 0.53 indicates lower market volatility, but a 30‑day volatility of 23% points to price swings. Analyst sentiment is positive (Buy, Outperform) with a median target of $25.25, reflecting confidence in the underlying loan portfolio’s resilience amid market turbulence. Overall, BXSL offers attractive income at a discount, but investors must weigh high leverage and dividend coverage concerns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near key support at $23.27
- Bearish MACD and decreasing volume
- High dividend yield but sustainability concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation upside to analyst target ~ $25.2
- Q1 earnings covered dividend and show portfolio resilience
- PE and P/B below industry averages
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Elevated leverage and debt‑to‑equity ratio
- Uncertain dividend sustainability with high payout ratio
- Stable sector fundamentals and low beta
Key Metrics & Analysis
Financial Health
Revenue Growth-9.00%
Profit Margin31.65%
P/E Ratio12.2
ROE7.11%
ROA4.99%
Debt/Equity131.71
P/B Ratio0.9
Op. Cash Flow$-634064000
Free Cash Flow$367.4M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI40.7
Support$23.27
Resistance$25.29
MA 20$24.06
MA 50$23.98
MA 200$26.12
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Target Price$25.10
Upside/Downside7.59%
GradeUndervalued
TypeBlend
Dividend Yield13.08%
Risk Assessment
Beta0.53
Volatility23.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.